Regencell Bioscience (RGC) Stock Slides 14% Into the Weekend: Latest News, Risks, and What to Watch Monday
NEW YORK, Dec. 27, 2025, 6:40 a.m. ET — Market closed Regencell Bioscience Holdings Limited (NASDAQ: RGC) stock heads into the weekend after a sharp Friday pullback, closing at $21.16, down 13.98% from the prior close of $24.60, in a move that put the name on multiple “top losers” radars as U.S. markets wrapped up a quiet post-Christmas session. aaii.com+2Investing.com+2 The late-week decline lands amid a broader backdrop that investors have come to associate with RGC in 2025: outsized percentage swings, intermittent liquidity, and a trading narrative that can move faster than traditional biotech fundamentals. In fact, AAII’s market-close recap